Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Vaccin Immunother. 2012 Dec 1;8(12):1867-8. doi: 10.4161/hv.21973. Epub 2012 Oct 2.

Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?

Author information

1
Syrian Research Cancer Centre of the Syrian Society against Cancer; Aleppo, Syria.

Abstract

We recently conducted several studies regarding the presence of high-risk HPVs in human cervical, colorectal and breast cancers in the Syrian population. Herein, we report that high-risk HPVs type 16, 18, 33, 45, 51, 52 and 58 are frequently present in colorectal cancer in this population. Therefore and based on previous studies and present data, we conclude that the most frequent high-risk HPV types, in the Syrian population, are 16, 18, 33, 35, 45, 51, 52 and 58. Thus, our data suggest that it will be useful to use the new generation of HPV vaccine to protect the Syrian population from high-risk HPVs and their associated cancers.

KEYWORDS:

Syrian population; colorectal cancer; high-risk HPV; vaccine

PMID:
23032164
PMCID:
PMC3656078
DOI:
10.4161/hv.21973
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center